{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:10:20Z","timestamp":1783469420655,"version":"3.55.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,19]],"date-time":"2018-07-19T00:00:00Z","timestamp":1531958400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005285","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Goi\u00e1s","doi-asserted-by":"crossref","award":["AUXPE 1665\/2016"],"award-info":[{"award-number":["AUXPE 1665\/2016"]}],"id":[{"id":"10.13039\/501100005285","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Saudi Pharmaceutical Journal"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.jsps.2018.07.003","type":"journal-article","created":{"date-parts":[[2018,7,20]],"date-time":"2018-07-20T17:22:37Z","timestamp":1532107357000},"page":"1155-1161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Trigger tools are as effective as non-targeted chart review for adverse drug event detection in intensive care units"],"prefix":"10.1007","volume":"26","author":[{"given":"Renato R.","family":"Martins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lunara T.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela G.","family":"Bessa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio M.","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"10.1016\/j.jsps.2018.07.003_b0005","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/pds.3422","article-title":"Improving adverse drug event detection in critically ill patients through screening intensive care unit transfer summaries","volume":"22","author":"Anthes","year":"2013","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.jsps.2018.07.003_b0010","doi-asserted-by":"crossref","first-page":"R204","DOI":"10.1186\/cc2872","volume":"8","author":"Bellomo","year":"2004","journal-title":"Crit Care"},{"key":"10.1016\/j.jsps.2018.07.003_b0015","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/PTS.0b013e3181990d51","article-title":"Incidence of adverse drug events and medication errors in intensive care units: a prospective multicenter study","volume":"5","author":"Benkirane","year":"2009","journal-title":"J. Patient Saf."},{"key":"10.1016\/j.jsps.2018.07.003_b0020","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.jcrc.2015.08.025","article-title":"The impact of endocrine supplementation on adverse events in septic shock","volume":"30","author":"Bissell","year":"2015","journal-title":"J. Crit. Care."},{"key":"10.1016\/j.jsps.2018.07.003_b0025","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/bcp.12189","article-title":"A new approach to identify, classify and count drug-related events","volume":"76","author":"B\u00fcrkle","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jsps.2018.07.003_b0030","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1377\/hlthaff.2011.0190","article-title":"\u2018Global Trigger Tool\u2019 shows that adverse events in hospitals may be ten times greater than previously measured","volume":"30","author":"Classen","year":"2011","journal-title":"Health Aff. (Millwood)"},{"key":"10.1016\/j.jsps.2018.07.003_b0035","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1097\/00003246-199708000-00014","article-title":"Preventable adverse drug events in hospitalized patients: a comparative study of intensive care and general care units","volume":"25","author":"Cullen","year":"1997","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.jsps.2018.07.003_b0040","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.2042-7174.2010.00058.x","article-title":"Testing a trigger tool as a method of detecting harm from medication errors in a UK hospital: a pilot study","volume":"18","author":"Franklin","year":"2010","journal-title":"Int. J. Pharm. Pract."},{"key":"10.1016\/j.jsps.2018.07.003_b0045","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.apnr.2010.02.004","article-title":"Research strategies that result in optimal data collection from the patient medical record","volume":"25","author":"Gregory","year":"2012","journal-title":"Appl. Nurs. Res."},{"key":"10.1016\/j.jsps.2018.07.003_b0050","unstructured":"Griffin, F.A., Resar, R.K., 2009. IHI Global Trigger Tool for Measuring Adverse Events (Second Edition) IHI Innovation Series white paper. Cambridge, MA: Institute for Healthcare Improvement. http:\/\/www.ihi.org (accessed 10 jan 2016)."},{"key":"10.1016\/j.jsps.2018.07.003_b0055","unstructured":"Institute for Healthcare Improvement, 2012. How-to Guide: Prevent Harm from High-Alert Medications. Institute for Healthcare Improvement: Cambridge, MA. http:\/\/www.ihi.org (accessed 17 jan 2016)."},{"key":"10.1016\/j.jsps.2018.07.003_b0060","unstructured":"Institute for Safe Medication Practices, 2014. ISMP's List of High Alert Medications. http:\/\/www.ismp.org\/Tools\/highalertmedications.pdf (accessed 31 jan 2016)."},{"key":"10.1016\/j.jsps.2018.07.003_b0065","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/pds.1761","article-title":"Adverse drug reactions in medical intensive care unit of a tertiary care hospital","volume":"18","author":"Joshua","year":"2009","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.jsps.2018.07.003_b0070","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1097\/CCM.0b013e318236f473","article-title":"Identification of risk factors for adverse drug events in critically ill patients","volume":"40","author":"Kane-Gill","year":"2012","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.jsps.2018.07.003_b0075","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1097\/CCM.0000000000000499","article-title":"A multicenter study of the point prevalence of drug-induced hypotension in the ICU","volume":"42","author":"Kane-Gill","year":"2014","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.jsps.2018.07.003_b0080","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/PTS.0b013e31827cdc3b","article-title":"Description and evaluation of adaptations to the Global Trigger Tool to enhance value to adverse event reduction efforts","volume":"9","author":"Kenneley","year":"2013","journal-title":"J. Patient Saf."},{"key":"10.1016\/j.jsps.2018.07.003_b0085","doi-asserted-by":"crossref","first-page":"e71045","DOI":"10.1371\/journal.pone.0071045","article-title":"Adverse drug events in older hospitalized patients: results and reliability of a comprehensive and structured identification strategy","volume":"8","author":"Klopotowska","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jsps.2018.07.003_b0090","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1001\/jama.282.3.267","article-title":"Pharmacist participation on physician rounds and adverse drug events in the intensive care unit","volume":"282","author":"Leape","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.jsps.2018.07.003_b0095","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2165\/00002018-200932010-00002","article-title":"Determinants of under-reporting of adverse drug reactions: a systematic review","volume":"32","author":"Lopez-Gonz\u00e1lez","year":"2009","journal-title":"Drug Saf."},{"key":"10.1016\/j.jsps.2018.07.003_b0100","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1007\/s00134-005-2762-6","article-title":"SAPS 3 - From evaluation of the patient to evaluation of the intensive care unit. Part 1: objectives, methods and cohort description","volume":"31","author":"Metnitz","year":"2005","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.jsps.2018.07.003_b0105","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/pds.3348","article-title":"Methodologies for the detection of adverse drug reactions: comparison of hospital databases, chart review and spontaneous reporting","volume":"22","author":"Miguel","year":"2013","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.jsps.2018.07.003_b0110","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s00134-005-2763-5","article-title":"SAPS 3 - From evaluation of the patient to evaluation of the intensive care unit. Part 2: Development of a prognostic model for hospital mortality at ICU admission","volume":"31","author":"Moreno","year":"2005","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.jsps.2018.07.003_b0115","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1136\/qshc.2004.010611","article-title":"Adverse drug events and medication errors: detection and classification methods","volume":"13","author":"Morimoto","year":"2004","journal-title":"Qual Saf Health Care."},{"key":"10.1016\/j.jsps.2018.07.003_b0120","first-page":"435","article-title":"Identifying causes of adverse events detected by an automated trigger tool through in-depth analysis","volume":"19","author":"Muething","year":"2010","journal-title":"Qual. Saf. Health Care."},{"key":"10.1016\/j.jsps.2018.07.003_b0125","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jsps.2018.07.003_b0130","doi-asserted-by":"crossref","first-page":"e004587","DOI":"10.1136\/bmjopen-2013-004587","article-title":"Corticosteroids and risk of gastrointestinal bleeding: a systematic review and meta-analysis","volume":"4","author":"Narum","year":"2014","journal-title":"BMJ. Open."},{"key":"10.1016\/j.jsps.2018.07.003_b0135","unstructured":"National Cancer Institute, 2010. Common Terminology Criteria for Adverse Events (CTCAE). v. 4.03. http:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic _applications\/docs\/ctcaev3.pdf (accessed 10 jan 2016)."},{"key":"10.1016\/j.jsps.2018.07.003_b0140","unstructured":"National Coordinating Council for Medication Error Reporting, 2001. NCCMERP index for categorizing medication errors algorithm. http:\/\/www.nccmerp.org\/sites\/default\/files\/indexColor2001-06-12.pdf (accessed 10 jan 2016)."},{"key":"10.1016\/j.jsps.2018.07.003_b0145","unstructured":"National Coordinating Council for Medication Error Reporting, 2015. Contemporary View of Medication\u2013Related Harm. A New Paradigm. http:\/\/www.nccmerp.org\/sites\/default\/files\/nccmerp_fact_sheet_2015-02-v91.pdf (accessed 10 jan 2016)."},{"key":"10.1016\/j.jsps.2018.07.003_b0150","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1177\/0091270010361258","article-title":"The importance of the pharmacist in reporting adverse drug reactions in the emergency department","volume":"50","author":"Ratz","year":"2010","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.jsps.2018.07.003_b0155","first-page":"18","article-title":"Mechanisms of adverse drug reactions","author":"Rawlins","year":"1991"},{"key":"10.1016\/j.jsps.2018.07.003_b0160","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00228-010-0987-y","article-title":"Adverse drug events in an intensive care unit of a university hospital","volume":"67","author":"Reis","year":"2011","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.jsps.2018.07.003_b0165","doi-asserted-by":"crossref","DOI":"10.1136\/qhc.12.suppl_2.ii39","article-title":"Methodology and rationale for the measurement of harm with trigger tools","volume":"12","author":"Resar","year":"2003","journal-title":"Qual. Saf. Health Care."},{"key":"10.1016\/j.jsps.2018.07.003_b0170","first-page":"585","article-title":"A trigger tool to identify adverse events in the intensive care unit","volume":"32","author":"Resar","year":"2006","journal-title":"Jt. Comm. J. Qual. Patient Saf."},{"key":"10.1016\/j.jsps.2018.07.003_b0175","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1097\/01.CCM.0000171609.91035.BD","article-title":"The critical care safety study: the incidence and nature of adverse events and serious medical errors in intensive care","volume":"33","author":"Rothschild","year":"2005","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.jsps.2018.07.003_b0180","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1136\/qhc.12.3.194","article-title":"Adverse drug event trigger tool: a practical method for measuring drug related harm","volume":"12","author":"Rozich","year":"2003","journal-title":"Qual. Saf. Health Care."},{"key":"10.1016\/j.jsps.2018.07.003_b0185","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/j.1475-6773.2010.01156.x","article-title":"Performance characteristics of a methodology to quantify adverse events over time in hospitalized patients","volume":"46","author":"Sharek","year":"2011","journal-title":"Health Serv. Res."},{"key":"10.1016\/j.jsps.2018.07.003_b0190","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1097\/CCM.0000000000001022","article-title":"A multicenter evaluation of off-label medication use and associated adverse drug reactions in adult medical ICUs","volume":"43","author":"Smithburger","year":"2015","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.jsps.2018.07.003_b0195","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa071366","article-title":"Hydrocortisone therapy for patients with septic shock","volume":"358","author":"Sprung","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jsps.2018.07.003_b0200","doi-asserted-by":"crossref","unstructured":"Vincent, J.L., Moreno, R., Takala, J., et al., 1996. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med., vol. 22, pp. 707\u2013710.","DOI":"10.1007\/BF01709751"},{"key":"10.1016\/j.jsps.2018.07.003_b0205","first-page":"1","article-title":"Incidence of medication errors and adverse drug events in the ICU: a systematic review","volume":"19","author":"Wilmer","year":"2010","journal-title":"Qual. Saf. Health Care."},{"key":"10.1016\/j.jsps.2018.07.003_b0210","series-title":"The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines","author":"World Health Organization,","year":"1992"},{"key":"10.1016\/j.jsps.2018.07.003_b0215","unstructured":"World Health Organization, 2009. The conceptual framework for the international classification for patient safety: final technical report. Geneva: World Health Organization. http:\/\/www.who.int\/patientsafety\/taxonomy\/icps_full_report.pdf (accessed 9 aug 2016)."},{"key":"10.1016\/j.jsps.2018.07.003_b0220","unstructured":"World Health Organization, 2016. About the ATC\/DDD system. Geneva: The Organization. http:\/\/www.whocc.no\/atcddd\/ (accessed 9 aug 2016)."}],"container-title":["Saudi Pharmaceutical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319016418301427?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319016418301427?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T17:31:22Z","timestamp":1736184682000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1319016418301427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":44,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S1319016418301427"],"URL":"https:\/\/doi.org\/10.1016\/j.jsps.2018.07.003","relation":{},"ISSN":["1319-0164"],"issn-type":[{"value":"1319-0164","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trigger tools are as effective as non-targeted chart review for adverse drug event detection in intensive care units","name":"articletitle","label":"Article Title"},{"value":"Saudi Pharmaceutical Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsps.2018.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University.","name":"copyright","label":"Copyright"}]}}